CooperCompanies stock holds steady as analysts see modest upside

CooperCompanies stock trades in the mid-$70s as of late August 2026, with recent quarterly results beating earnings expectations and Wall Street projecting moderate upside from current levels.

CooperCompanies (US21664P1039) stock traded at $75.80 on August 25, 2026, giving investors a mid-$70s entry point after a period of steady performance.

Analysts project moderate upside

Per market data compiled in a stock-forecast overview dated August 21, 2026, CooperCompanies shares closed that session at $76.22, serving as a recent reference level for investors. The same overview highlights that the average 12-month price target for the stock stands at $81.64, implying upside of 7.11% from that $76.22 close, with individual analyst targets ranging from $61.00 to $103.00. In addition, several recent portfolio-disclosure alerts note that institutional investors have been adding exposure to CooperCompanies, framing the stock as a holding with balanced risk and return expectations.

Recent earnings beat expectations

In its second quarter of fiscal 2026, CooperCompanies reported adjusted earnings per share of $1.21, exceeding the prevailing earnings consensus by 10%. In the same period, the company generated revenue of $1.08 billion, which came in 2.6% above the then-current consensus expectation. The combination of a double-digit percentage earnings surprise and a mid-single-digit revenue beat underscored management’s ability to convert top-line growth into profits, while also extending a track record of positive earnings surprises over the most recent four quarters.

These second-quarter figures provide an important reference point for evaluating the stock’s valuation in late August 2026. With Wall Street’s average price target at $81.64 against the recent $76.22 close, the implied 7.11% upside is broadly consistent with a company that is growing earnings at a measured pace while maintaining a solid competitive position in its core markets.

Product focus: contact lenses and women’s health

CooperCompanies operates through businesses that focus on medical devices, including contact lenses and women’s health products, aiming to serve long-term structural demand in vision care and related segments. The company’s product portfolio and recurring-revenue characteristics are central to how investors assess its earnings stability and growth potential, particularly in light of recent quarterly results that have exceeded expectations on both revenue and earnings per share.

Stock snapshot and investor view

As of the close on August 21, 2026, CooperCompanies stock stood at $76.22, with analysts collectively targeting $81.64 over the next 12 months based on the latest compiled estimates. The modest gap between the current price and the consensus target reflects expectations for continued, but measured, earnings growth following the company’s second-quarter fiscal 2026 revenue of $1.08 billion and adjusted EPS of $1.21.

Fact box

Company: CooperCompanies Inc.
ISIN: US21664P1039
Ticker: COO
Exchange: Nasdaq
Price (as of August 21, 2026, 4:00 p.m. ET): $76.22 USD
Sector / Industry: Health care / Medical devices